Free Priority Shipping on Orders Over $250

Research entry

CJC-1295 / Ipamorelin (No DAC)

Two compounds that act on different receptors

In plain terms

This blend pairs CJC-1295 (without DAC) with ipamorelin. They reach the growth-hormone axis by two separate routes — CJC-1295 at the GHRH receptor, ipamorelin at the ghrelin receptor — which is why they are studied together rather than separately. The published work is in animal and cell models.

Research overview

CJC-1295 is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH). Ipamorelin is a selective growth hormone secretagogue. Laboratory research has investigated the combination for its synergistic effects on pulsatile growth hormone release and IGF-1 signaling. Studies have examined their potential roles in tissue repair and metabolic research models.

What has been studied

  1. 1

    Two receptors, two routes

    CJC-1295 acts at the GHRH receptor and ipamorelin at the ghrelin receptor. They are studied together because they reach the same axis by separate paths.

  2. 2

    Selectivity

    Ipamorelin is studied partly for what it does not do — research has looked at its selectivity compared with earlier ghrelin-receptor compounds that also moved cortisol and prolactin.

  3. 3

    Pulse patterns

    Animal work has measured the shape and timing of growth-hormone release rather than only its total amount.

Research articles

All research cited here is drawn from peer-reviewed scientific literature and provided for informational and educational purposes only. PureChain products are sold strictly for laboratory and research use — not for human consumption, therapeutic use, or clinical application of any kind. Nothing on this page is medical advice.